Global Risedronate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Risedronate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
Risedronate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Risedronate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Postmenopausal Osteoporosis and Men with Osteoporosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Risedronate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Risedronate key manufacturers include Merck, Amgen, Teva, Mylan, Apotex, Sanofi, Abbott, Novartis and Tecoland, etc. Merck, Amgen, Teva are top 3 players and held % sales share in total in 2022.
Risedronate can be divided into 5 mg Tablets, 35 mg Tablets, 75 mg Tablets and 150 mg Tablets, etc. 5 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Risedronate is widely used in various fields, such as Postmenopausal Osteoporosis and Men with Osteoporosis, etc. Postmenopausal Osteoporosis provides greatest supports to the Risedronate industry development. In 2022, global % sales of Risedronate went into Postmenopausal Osteoporosis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Risedronate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
Segment by Type
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Postmenopausal Osteoporosis
Men with Osteoporosis
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Risedronate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Risedronate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Risedronate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Risedronate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Risedronate introduction, etc. Risedronate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Risedronate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Risedronate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Risedronate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Postmenopausal Osteoporosis and Men with Osteoporosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Risedronate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Risedronate key manufacturers include Merck, Amgen, Teva, Mylan, Apotex, Sanofi, Abbott, Novartis and Tecoland, etc. Merck, Amgen, Teva are top 3 players and held % sales share in total in 2022.
Risedronate can be divided into 5 mg Tablets, 35 mg Tablets, 75 mg Tablets and 150 mg Tablets, etc. 5 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Risedronate is widely used in various fields, such as Postmenopausal Osteoporosis and Men with Osteoporosis, etc. Postmenopausal Osteoporosis provides greatest supports to the Risedronate industry development. In 2022, global % sales of Risedronate went into Postmenopausal Osteoporosis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Risedronate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
Segment by Type
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Risedronate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Risedronate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Risedronate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Risedronate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Risedronate introduction, etc. Risedronate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Risedronate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.